MAGGI, Paolo
 Distribuzione geografica
Continente #
EU - Europa 16.059
AS - Asia 9.219
NA - Nord America 4.092
SA - Sud America 1.354
AF - Africa 99
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 30.832
Nazione #
RU - Federazione Russa 12.295
US - Stati Uniti d'America 3.981
SG - Singapore 3.127
CN - Cina 2.278
IE - Irlanda 2.260
HK - Hong Kong 1.621
BR - Brasile 1.160
VN - Vietnam 774
IT - Italia 679
KR - Corea 485
IN - India 456
GB - Regno Unito 195
JP - Giappone 180
DE - Germania 177
FR - Francia 102
AR - Argentina 89
BD - Bangladesh 51
NL - Olanda 48
AT - Austria 44
UA - Ucraina 43
FI - Finlandia 40
MX - Messico 40
GR - Grecia 39
CA - Canada 36
IQ - Iraq 36
CZ - Repubblica Ceca 34
ID - Indonesia 33
EC - Ecuador 27
TR - Turchia 26
CO - Colombia 24
SE - Svezia 24
MA - Marocco 21
ZA - Sudafrica 21
PL - Polonia 19
PY - Paraguay 16
ES - Italia 15
PK - Pakistan 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 13
MY - Malesia 13
PH - Filippine 13
KE - Kenya 12
UY - Uruguay 12
TN - Tunisia 11
UZ - Uzbekistan 10
IL - Israele 9
SA - Arabia Saudita 9
AU - Australia 8
BE - Belgio 8
TH - Thailandia 8
ET - Etiopia 7
JO - Giordania 7
NP - Nepal 7
HN - Honduras 6
KZ - Kazakistan 6
LB - Libano 6
LT - Lituania 6
TT - Trinidad e Tobago 6
DZ - Algeria 5
PE - Perù 5
PT - Portogallo 5
AL - Albania 4
CL - Cile 4
CM - Camerun 4
CR - Costa Rica 4
EG - Egitto 4
JM - Giamaica 4
BG - Bulgaria 3
BH - Bahrain 3
CG - Congo 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
OM - Oman 3
PA - Panama 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CD - Congo 2
IR - Iran 2
MD - Moldavia 2
ML - Mali 2
NI - Nicaragua 2
NO - Norvegia 2
SI - Slovenia 2
UG - Uganda 2
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
EU - Europa 1
GP - Guadalupe 1
HT - Haiti 1
Totale 30.821
Città #
Moscow 4.330
Dublin 2.259
Hong Kong 1.614
Santa Clara 935
Hefei 875
Singapore 837
San Jose 599
Seoul 483
Ashburn 408
Bengaluru 350
Ho Chi Minh City 274
Hanoi 169
Boardman 143
The Dalles 139
Chandler 135
New York 134
São Paulo 99
Jacksonville 86
Princeton 75
Dallas 74
Roxbury 74
Naples 64
Da Nang 53
Los Angeles 52
Cambridge 49
Beijing 45
Falkenstein 43
Pune 41
Haiphong 40
Amsterdam 35
Brasília 35
Rio de Janeiro 32
Bremen 31
Medford 30
Nuremberg 29
Brno 27
Milan 27
Ann Arbor 26
Belo Horizonte 26
Munich 26
Jinan 24
Des Moines 23
Caserta 22
Vienna 22
Rome 20
Biên Hòa 19
Atlanta 18
Curitiba 18
Guangzhou 18
Helsinki 18
Wilmington 18
Dhaka 17
Tokyo 17
Toronto 17
Bari 16
Istanbul 16
Warsaw 16
Napoli 15
Salvador 15
Changsha 14
Chennai 14
Chicago 14
Frankfurt am Main 14
Hải Dương 14
Ninh Bình 14
Palermo 14
Shenzhen 14
Turku 14
Brooklyn 13
Fortaleza 13
Kuala Lumpur 13
Porto Alegre 13
Thái Bình 13
Zhengzhou 13
Baghdad 12
Baku 12
Buenos Aires 12
Casablanca 12
Council Bluffs 12
Hangzhou 12
San Francisco 12
Tianjin 12
Charlotte 11
London 11
Mumbai 11
Orem 11
Carapicuíba 10
Guarulhos 10
Hebei 10
Johannesburg 10
Montevideo 10
Paris 10
Quito 10
Tashkent 10
Asunción 9
Bogotá 9
Campinas 9
Can Tho 9
Goiânia 9
Guayaquil 9
Totale 15.630
Nome #
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 183
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 179
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 164
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 157
[Acquired immunodeficiency syndrome and pulmonary Mycobacterium xenopi infection. Role of computerized tomography] 152
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 151
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 147
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients 145
Adipocyte differentiation of 3T3-L1 cells under TAF, TDF and INSTIs selective challenge: an in vitro model 142
Hyperglycaemia on admission to hospital and COVID-19 140
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 138
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 136
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 134
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 133
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 131
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 129
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. 128
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 128
A color doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1 positive patients 126
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing 126
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 125
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 125
Archi-Prevaleat Project. A National Register of Color-Doppler Ultrasonography of the Epi-Aortic Vessels in Patients Living with HIV. 120
A comprehensive development agenda on tenofovir alafenamide in clinical practice 118
Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study 117
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naïve HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 116
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 116
Genomic Characterization of the Emerging SARS-CoV-2 Lineage in Two Districts of Campania (Italy) Using Next-Generation Sequencing 115
. Prevaleat study (Premature Vascular Lesions and Antiretroviral Therapy). A comparative study between patients treated with PI-including regimens vs NNRTI-including regimens 114
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 114
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 113
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study 112
. Long term non progressors among IVDA: behavioural, clinical and virological aspects 112
. Cutaneous reactions in HIV-1 positive patients treated with enfuvirtide 112
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 112
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 111
Implications of AB0 blood group in hypertensive patients with covid-19 110
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 109
Early predictors of clinical deterioration in a cohort of outpatients with COVID-19 in southern Italy: A multicenter observational study 107
A Cyanobacterium-Like Body found in the stools of an HIV+ patient with diarrhoea 107
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 107
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study 107
A case of human brucellosis caused by accidental injection of animal vaccine 106
Accettabilità del condom: studio su una coorte di tossicodipendenti e loro partners 105
Weight gain in dolutegravir containing regimens in the observational SCOLTA cohort. 104
Evaluation of lipid profile in HIV naive patients, treated by TAF-based regimens. 104
Abnormalities of abdominal wall: a case of venous displasia between external mammary common femoral veins and right iliac axis with varicocele 103
Isolamento dell' HIV e antigenemia P24 103
A retrospective study on non transfusional HCV hepatitis in hemodialized patients 102
Alexithymia is linked to neurocognitive function independently of sociodemographic and clinical predictors. A multicentric HIV cohort study 102
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 101
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study. 101
. First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) 100
Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control? 100
Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy 100
A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect" 98
A nodular pulmonary lesion due to Linguatula serrata in an HV-positive man 97
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study 97
Occupational risk linked to leptospirae in Apulia 96
Squillace N, Menzaghi B, Migliorino GM, De Socio GV, Passerini S, Martinelli C, Mameli MS, Maggi P, Falasca K, Cordier L, Celesia BM, Salomoni E, Di Biagio A, Pellicanò G, Bonfanti P. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide and cholesterol increase: impact on cardiovascular risk assessment. Journal of HIV and Ageing. 95
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use. 95
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 95
A color-doppler ultrasonographic comparative study between patients treated with PI-including regimens vs NNRTI-including regimens (Prevaleat study). 95
Dolutegravir safety in a real-life setting: results Title from the SCOLTA cohort 94
Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients 93
Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens 93
Primary prophylaxis against pneumocystis carinii and Toxoplasma gondii with low dose cotrimoxazole: a case-control study 92
Ruolo della diagnostica con Fibroscan nella valutazione della fibrosi epatica in pazienti HIV-positivi. Confronto tra soggetti monoinfetti versus coinfetti 91
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 91
Archi-Prevaleat project. A National Register of color-Doppler ultrasonography of the epi-aortic vessels in Patients Living with HIV. 91
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 90
Cardiovascular disease risk in liver transplant recipients transplanted due to chronic viral hepatitis 90
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 89
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 89
HCV infection occupational hazard at dialysis units and virus spread among relatives of dialyzed patients 88
Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients 88
Early markers of mitochondrial tubular injury in patients treated with tenofovir vs abacavir-including backbones. 87
HIV Effectiveness Italian Conference; HEFFICON Study Group 87
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 87
Smoking habits in HIV-infected people from Italy: a cross-sectional analysis of the STOPSHIV cohort 87
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN) 87
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 87
Cardiovascular risk in advanced naïve HIV-infected patients starting antiretroviral therapy: Comparison of three different regimens - PREVALEAT II cohort 87
Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV? 86
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 86
Cardiovascular risk assessment in antiretroviral-naive patients 85
Haart and cardiovascular toxicity: a chapter to rewrite? 85
Epatite NANB in pazienti emodializzati: formulazione di un protocollo diagnostico 84
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 84
Incident diabetes in course of antiretroviral therapy 83
Safety and metabolic impact of darunaviur/cobicistat in a real-life setting. Results from the SCOLTA study cohort. 83
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience 83
Italian Multicentric Study on Nosocomial and Occupational Risk of Blood-Borne Infections in Dialysis. Prevalence of Human Immunodeficiency virus, Hepatitis B Virus and Hepatitis C Virus among dialysis patients. 82
Utilità del dosaggio della neopterina e della P24 per la stadiazione dell' infezione da HIV 82
Movement disorders in patients with cerebral toxoplasmosis and AIDS 82
Citrati urinari ed escrezione di glucosaminoglicani in soggetti sani ed in pazienti con nefrolitiasi ossalocalcica recidivante 81
BONE TURN-OVER MARKERS IN HIV POSITIVE PATIENTS AFTER HAART: TENOFOVIR (TDF) plus EMTRICITABINE (FTC) plus ATAZANAVIR/RITONAVIR (ATV/R)-VS.-TDF plus FTC plus EFAVIRENZ (EFV): RESULTS OF INCA TRIAL 80
Precocious lesions of the carotid vessels in HIV-1 patients treated with protease inhibitors 80
Therapy with Isoprinosine in asymptomatic subjects infected by HIV 80
Le malattie infettive nelle grandi catastrofi 80
Totale 10.661
Categoria #
all - tutte 107.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.214


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 39 38 7
2021/2022446 6 16 4 7 145 9 19 11 22 17 25 165
2022/20232.335 100 17 10 12 100 39 320 45 1.654 10 10 18
2023/20241.638 29 55 45 164 695 170 23 11 15 17 108 306
2024/20255.433 18 31 9 209 926 170 878 543 838 987 398 426
2025/202620.865 791 1.811 1.558 1.120 1.464 11.543 1.066 521 758 233 0 0
Totale 31.316